Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study.

Tülay Canda Ekrem Yavuz Necmettin Özdemir Sennur İlvan Serpil Dizbay Sak Merih Guray Durak Sitki Tuzlali Osman Zekioglu Atakan Demir Handan Onur Kasım Üstündağ Burçe Göktaş

Published in: European journal of breast health (2018)

This study showed that in general there is sufficiently good agreement between the reference laboratory and the participating centers for immunohistochemical HER2 assessment.

Keyphrases

breast cancer risk